PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1466179
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1466179
India Oncology Drugs Market, By Drug Class; By Therapy Type; By Indication; By Dosage Form; By Distribution Channel; By Region, Trend Analysis, Competitive Landscape & Forecast, 2019-2030
India Oncology Drugs Market Size Booming at Significant CAGR of almost 8% to Touch USD 3.75 Billion by 2030
India Oncology Drugs Market is flourishing due to growing awareness about cancer drugs, treatments, and therapies, government initiatives for improving cancer care, and increasing adoption of advanced technologies like minimally invasive surgeries.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the India Oncology Drugs Market size by value at USD 2.18 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the India Oncology Drugs Market size to expand at a CAGR of 7.89% reaching a value of USD 3.75 billion by 2030. The Oncology Drugs Market in India is propelled by increasing awareness regarding cancer and its treatments, escalating disposable incomes, and enhanced healthcare accessibility. The rapid expansion of India's oncology drug market necessitates innovative solutions due to increasing cancer incidence, patient numbers, and adoption of novel therapies. With an estimated 1.4 million new cancer cases projected for 2020, the country faces a rising public health challenge. However, over 80% of patients present with advanced disease, highlighting issues with awareness, accessibility, and affordability. Private hospitals cater to 60% to 75% of cancer patients, but they often encounter high out-of-pocket costs and financial strain. By 2025, India's cancer burden is expected to surpass 1.5 million cases.
Opportunities - Increasing reimbursement and insurance for cancer treatments
In India, the Central Drugs Standard Control Organization (CDSCO) oversees the approval and regulation of medical products, including cancer treatments. Additionally, the country has established a national healthcare insurance system aimed at reimbursing various medical expenses, including those related to cancer therapy. This system strives to ensure universal access to essential healthcare services, irrespective of individuals' financial capabilities. India has also implemented the "National List of Essential Medicines" (NLEM), comprising vital medications. Furthermore, specific programs within the Indian healthcare framework, like the National Health Protection Scheme (Ayushman Bharat), may facilitate access to certain lung cancer treatments. This reflects the increasing focus on cancer health insurances in the country.
Impact of Escalating Geopolitical Tensions on India Oncology Drugs Market
Geopolitical tensions can have a multifaceted impact on the India Oncology Drugs Market. Heightened uncertainties may disrupt supply chains, leading to potential shortages of critical medications and raw materials, thereby affecting drug availability and pricing. Moreover, increased geopolitical instability can deter foreign investments and collaborations in the pharmaceutical sector, hampering innovation and research efforts. Trade barriers and sanctions could further exacerbate these challenges, limiting market growth opportunities and access to advanced therapies. As a result, navigating geopolitical risks becomes imperative for stakeholders in the India Oncology Drugs Market to ensure continued resilience and sustainability amidst evolving global dynamics.
India Oncology Drugs Market
Segmental Coverage
India Oncology Drugs Market - By Therapy Type
Based on therapy type, the India Oncology Drugs Market is divided into Chemotherapy, Targeted Therapy, and Immunotherapy segments. The immunotherapy segment is expected to hold the highest share in the India Oncology Drugs Market by therapy type during the forecast period. Immunotherapy, a promising cancer treatment, activates the body's immune system to combat the disease, showing efficacy primarily in advanced stage patients. Its suitability varies based on cancer type and patient condition. Effective against diverse cancers like lung, kidney, bladder, melanoma, cervical, and lymphoma, a study in India revealed nivolumab's (Opdivo) low doses prolonged survival in advanced head and neck cancer patients at 6% of Western dosages, potentially reducing costs. Clinical trials combining minimal nivolumab doses with standard head and neck cancer treatments in India hint at improving patient outcomes. Amid rising cancer rates, innovations aimed at enhancing cancer care contribute to market growth.
Competitive Landscape
The India Oncology Drugs Market is fragmented, with numerous players serving the market. The key players dominating the India Oncology Drugs Market include Roche, Novartis Oncology, Celgene, Johnson & Johnson, AbbVie, Arlak Biotech, Bristol-Myers Squibb, Pfizer Inc, Merck & Co, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Amgen Inc, Getwell Pharma, and Intelicure Lifesciences. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and the India Oncology Drugs Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the India Oncology Drugs Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. India Oncology Drugs Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising cancer burden
- 3.2.1.2. Growing awareness about cancer
- 3.2.1.3. Government initiatives for improving cancer care
- 3.2.1.4. Increasing adoption of advanced technologies like minimally invasive surgeries
- 3.2.2. Restraints
- 3.2.2.1. High cost of treatment
- 3.2.2.2. Limited availability of cancer care facilities, especially in rural areas
- 3.2.2.3. Shortage of qualified oncologists and other healthcare professionals specializing in cancer treatment
- 3.2.3. Opportunities
- 3.2.3.1. Strong demand for cost-effective oncology drugs in India
- 3.2.3.2. Increasing number of cancer health insurances
- 3.2.4. Challenges
- 3.2.4.1. Lack of early detection awareness
- 3.2.4.2. Stringent regulation and patent expiry
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. India Oncology Drugs Market: Pricing Analysis
5. India Oncology Drugs Market: Marketing Strategies
6. India Oncology Drugs Market Overview
- 6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Drug Class
- 6.2.1.1. Cytotoxic Drugs
- 6.2.1.2. Targeted Drugs
- 6.2.1.3. Hormonal Drugs
- 6.2.1.4. Others
- 6.2.2. By Therapy Type
- 6.2.2.1. Chemotherapy
- 6.2.2.2. Targeted Therapy
- 6.2.2.3. Immunotherapy
- 6.2.3. By Indication
- 6.2.3.1. Lung Cancer
- 6.2.3.2. Stomach Cancer
- 6.2.3.3. Colorectal Cancer
- 6.2.3.4. Breast Cancer
- 6.2.3.5. Prostate Cancer
- 6.2.3.6. Others
- 6.2.4. By Dosage Form
- 6.2.4.1. Solid
- 6.2.4.2. Liquid
- 6.2.4.3. Injectable
- 6.2.5. By Distribution Channel
- 6.2.5.1. Hospital Pharmacies
- 6.2.5.2. Retail Pharmacies
- 6.2.5.3. Online Pharmacies
- 6.2.6. By Region
- 6.2.6.1. North India
- 6.2.6.2. South India
- 6.2.6.3. East India
- 6.2.6.4. West India
- 6.2.1. By Drug Class
7. North India Oncology Drugs Market Overview
- 7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Drug Class
- 7.2.2. By Therapy Type
- 7.2.3. By Indication
- 7.2.4. By Dosage Form
- 7.2.5. By Distribution Channel
8. South India Oncology Drugs Market Overview
- 8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Drug Class
- 8.2.2. By Therapy Type
- 8.2.3. By Indication
- 8.2.4. By Dosage Form
- 8.2.5. By Distribution Channel
9. East India Oncology Drugs Market Overview
- 9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Drug Class
- 9.2.2. By Therapy Type
- 9.2.3. By Indication
- 9.2.4. By Dosage Form
- 9.2.5. By Distribution Channel
10. West India Oncology Drugs Market Overview
- 10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Drug Class
- 10.2.2. By Therapy Type
- 10.2.3. By Indication
- 10.2.4. By Dosage Form
- 10.2.5. By Distribution Channel
11. India Oncology Drugs Market: Import & Export
12. Competitive Landscape
- 12.1. List of Key Players and Their Offerings
- 12.2. India Oncology Drugs Company Market Share Analysis, 2023
- 12.3. Competitive Benchmarking, By Operating Parameters
- 12.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
13. Impact of Geopolitical Tensions in India Oncology Drugs Market
14. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 14.1. Roche
- 14.2. Novartis Oncology
- 14.3. Celgene
- 14.4. Johnson & Johnson
- 14.5. AbbVie
- 14.6. Arlak Biotech
- 14.7. Bristol-Myers Squibb
- 14.8. Pfizer Inc
- 14.9. Merck & Co
- 14.10. Eli Lilly and Company
- 14.11. AstraZeneca plc
- 14.12. Bayer AG
- 14.13. Amgen Inc
- 14.14. Getwell Pharma
- 14.15. Intelicure Lifesciences
- 14.16. Other Prominent Players
15. Key Strategic Recommendations
16. Research Methodology
- 16.1. Qualitative Research
- 16.1.1. Primary & Secondary Research
- 16.2. Quantitative Research
- 16.3. Market Breakdown & Data Triangulation
- 16.3.1. Secondary Research
- 16.3.2. Primary Research
- 16.4. Breakdown of Primary Research Respondents, By Region
- 16.5. Assumption & Limitation
* Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
- Figure 1 India Oncology Drugs Market Segmentation
- Figure 2 India Oncology Drugs Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Figure 5 India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Figure 6 India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Figure 7 India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Figure 8 India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Figure 9 India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Figure 10 India Oncology Drugs Market Share, By Region, By Value (USD Billion), 2019-2030
- Figure 11 North India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Figure 12 North India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Figure 13 North India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Figure 14 North India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Figure 15 North India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Figure 16 North India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Figure 17 South India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Figure 18 South India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Figure 19 South India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Figure 20 South India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Figure 21 South India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Figure 22 India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Figure 23 East India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Figure 24 East India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Figure 25 East India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Figure 26 East India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Figure 27 East India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Figure 28 East India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Figure 29 West India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Figure 30 West India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Figure 31 West India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Figure 32 West India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Figure 33 West India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Figure 34 West India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
List of Tables
- Table 1 India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Table 2 India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Table 3 India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Table 4 India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Table 5 India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Table 6 India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Table 7 India Oncology Drugs Market Share, By Region, By Value (USD Billion), 2019-2030
- Table 8 North India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Table 9 North India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Table 10 North India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Table 11 North India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Table 12 North India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Table 13 North India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Table 14 South India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Table 15 South India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Table 16 South India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Table 17 South India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Table 18 South India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Table 19 South India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Table 20 East India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Table 21 East India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Table 22 East India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Table 23 East India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Table 24 East India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Table 25 East India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Table 26 West India Oncology Drugs Market Size, By Value (USD Billion), 2019-2030
- Table 27 West India Oncology Drugs Market Share, By Drug Class, By Value (USD Billion), 2019-2030
- Table 28 West India Oncology Drugs Market Share, By Therapy Type, By Value (USD Billion), 2019-2030
- Table 29 West India Oncology Drugs Market Share, By Indication, By Value (USD Billion), 2019-2030
- Table 30 West India Oncology Drugs Market Share, By Dosage Form, By Value (USD Billion), 2019-2030
- Table 31 West India Oncology Drugs Market Share, By Distribution Channel, By Value (USD Billion), 2019-2030
- Table 32 Roche Company Overview
- Table 33 Roche Company Overview
- Table 34 Novartis Oncology Company Overview
- Table 35 Novartis Oncology Company Overview
- Table 36 Celgene Company Overview
- Table 37 Celgene Company Overview
- Table 38 Johnson & Johnson Company Overview
- Table 39 Johnson & Johnson Company Overview
- Table 40 AbbVie Company Overview
- Table 41 AbbVie Company Overview
- Table 42 Arlak Biotech Company Overview
- Table 43 Arlak Biotech Company Overview
- Table 44 Bristol-Myers Squibb Company Overview
- Table 45 Bristol-Myers Squibb Company Overview
- Table 46 Pfizer Inc Company Overview
- Table 47 Pfizer Inc Company Overview
- Table 48 Merck & Co Company Overview
- Table 49 Merck & Co Company Overview
- Table 50 Eli Lilly and Company Overview
- Table 51 Eli Lilly and Company Overview
- Table 52 AstraZeneca plc Company Overview
- Table 53 AstraZeneca plc Company Overview
- Table 54 Bayer AG Company Overview
- Table 55 Bayer AG Company Overview
- Table 56 Amgen Inc Company Overview
- Table 57 Amgen Inc Company Overview
- Table 58 Getwell Pharma Company Overview
- Table 59 Getwell Pharma Company Overview
- Table 60 Intelicure Lifesciences Company Overview
- Table 61 Intelicure Lifesciences Company Overview
